A top-down view of the tumor microenvironment: Structure, cells and signaling

Frontiers in Cell and Developmental Biology

Volumn 3, Issue MAY, 2015, Pages

  Bhome, Rahul ^a,b   Bullock, Marc D ^a,c   Al Saihati, Hajir A ^a   Goh, Rebecca W ^a   Primrose, John N ^b   Sayan, A Emre ^a   Mirnezami, Alex H ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer stroma; Cancer associated fibroblast; Extracellular matrix; MicroRNA; Tumor microenvironment

Indexed keywords

EID: 84934309900     PISSN: None     EISSN: 2296634X     Source Type: Journal    
DOI: 10.3389/fcell.2015.00033     Document Type: Short Survey

References (118)

1. Allen, E., Walters, I. B., and Hanahan, D. (2011). Brivanib, a dual FGF/VEGF inhibitor, is active both first and second line against mouse pancreatic neuroendocrine tumors developing adaptive/evasive resistance to VEGF inhibition. Clin. Cancer Res. 17, 5299-5310. doi: 10.1158/1078-0432.CCR-10-2847
2. Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., et al. (2004). Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6, 17-32 doi: 10.1016/j.ccr.2004.06.010
3. Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., et al. (2001). Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol. 166, 678-689. doi: 10.4049/jimmunol.166.1.678
4. Anand-Apte, B., Bao, L., Smith, R., Iwata, K., Olsen, B. R., Zetter B., et al. (1996). A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth. Biochem. Cell Biol. 74, 853-862. doi: 10.1139/o96-090
5. Asangani, I. A., Rasheed, S. A., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., et al. (2008). MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27, 2128-2136. doi: 10.1038/sj.onc.1210856
6. Bai, H., Weng, Y., Bai, S., Jiang, Y., Li, B., He, F., et al. (2014). CCL5 secreted from bone marrow stromal cells stimulates the migration and invasion of Huh7 hepatocellular carcinoma cells via the PI3K-Akt pathway. Int. J. Oncol. 45, 333-343. doi: 10.3892/ijo.2014.2421
7. Bates, G. J., Fox, S. B., Han, C., Leek, R. D., Garcia, J. F., Harris, A. L., et al. (2006). Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J. Clin. Oncol. 24, 5373-5380. doi: 10.1200/JCO.2006.05.9584
8. Ben-Izhak, O., Kaplan-Cohen, V., Ilan, N., Gan, S., Vlodavsky, I., and Nagler, R. (2006). Heparanase expression in malignant salivary gland tumors inversely correlates with long-term survival. Neoplasia 8, 879-884. doi: 10.1593/neo.06382
9. Bharadwaj, U., Li, M., Zhang, R., Chen, C., and Yao, Q. (2007). Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res. 67, 5479-5488. doi: 10.1158/0008-5472.CAN-06-3963
10. Boehm, T., Folkman, J., Browder, T., and O'Reilly, M. S. (1997). Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390, 404-407. doi: 10.1038/37126
11. Boelens, M. C., Wu, T. J., Nabet, B. Y., Xu, B., Qiu, Y., Yoon, T., et al. (2014). Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways. Cell 23, 499-513. doi: 10.1016/j.cell.2014.09.051
12. Bonnans, C., Chou, J., and Werb, Z. (2014). Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell Biol. 15, 786-801. doi: 10.1038/nrm3904
13. Branco-Price, C., Zhang, N., Schnelle, M., Evans, C., Katschinski, D. M., Liao, D., et al. (2012). Endothelial cell HIF-1alpha and HIF-2alpha differentially regulate metastatic success. Cancer Cell 21, 52-65. doi: 10.1016/j.ccr.2011.11.017
14. Bronisz, A., Godlewski, J., Wallace, J. A., Merchant, A. S., Nowicki, M. O., Mathsyaraja, H., et al. (2012). Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat. Cell Biol. 14, 159-167. doi: 10.1038/ncb2396
15. Bullock, M. D., Pickard, K. M., Nielsen, B. S., Sayan, A. E., Jenei, V., Mellone, M., et al. (2013). Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression. Cell Death Dis. 4:e684. doi: 10.1038/cddis.2013.213
16. Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., et al. (2002). Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 99, 15524-15529. doi: 10.1073/pnas.242606799
17. Carmeliet, P., and Jain, R. K. (2011). Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat. Rev. Drug Discov. 10, 417-427. doi: 10.1038/nrd3455
18. Chang, K. C., Lu, Y. C., Lin, M. J., Chen, H. Y., and Jin, Y. T. (2011). Desmoplastic tumour-associated stroma versus neural tissue in central nervous system metastasis: effects of different microenvironments on tumour growth. Histopathology 59, 31-39. doi: 10.1111/j.1365-2559.2011.03898.x
19. Chaux, P., Favre, N., Martin, M., and Martin, F. (1997). Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats. Int. J. Cancer 72, 619-624
20. Che, Y. L., Luo, S. J., Li, G., Cheng, M., Gao, Y. M., Li, X. M., et al. (2015). The C3G/Rap1 pathway promotes secretion of MMP-2 and MMP-9 and is involved in serous ovarian cancer metastasis. Cancer Lett. 359, 241-249. doi: 10.1016/j.canlet.2015.01.019
21. Chen, L. C., Tu, S. H., Huang, C. S., Chen, C. S., Ho, C. T., Lin, H. W., et al. (2012). Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway. Breast Cancer Res. Treat. 134, 989-1004. doi: 10.1007/s10549-012-1986-8
22. Chen, P., Huang, Y., Bong, R., Ding, Y., Song, N., Wang, X., et al. (2011). Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner. Clin. Cancer Res. 17, 7230-7239. doi: 10.1158/1078-0432.CCR-11-1354
23. Chiang, C. L., Balint, K., Coukos, G., and Kandalaft, L. E. (2015). Potential approaches for more successful dendritic cell-based immunotherapy. Expert Opin. Biol. Ther. 1-14. doi: 10.1517/14712598.2015.1000298
24. Cortez-Retamozo, V., Etzrodt, M., Newton, A., Rauch, P. J., Chudnovskiy, A., Berger, C., et al. (2012). Origins of tumor-associated macrophages and neutrophils. Proc. Natl. Acad. Sci. U.S.A. 109, 2491-2496. doi: 10.1073/pnas.1113744109
25. Daurkin, I., Eruslanov, E., Stoffs, T., Perrin, G. Q., Algood, C., Gilbert, S. M., et al. (2011). Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway. Cancer Res. 71, 6400-6409. doi: 10.1158/0008-5472.CAN-11-1261
26. Delinassios, J. G., and Kottaridis, S. D. (1984). Interactions between human fibroblasts and HeLa cells in vitro. Biol. Cell 50, 9-16. doi: 10.1111/j.1768-322X.1984.tb00250.x
27. Denys, H., Braems, G., Lambein, K., Pauwels, P., Hendrix, A., De Boeck, A., et al. (2009). The extracellular matrix regulates cancer progression and therapy response: implications for prognosis and treatment. Curr. Pharm. Des. 15, 1373-1384. doi: 10.2174/138161209787846711
28. De Wever, O., Nguyen, Q. D., Van Hoorde, L., Bracke, M., Bruyneel, E., Gespach, C., et al. (2004). Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J. 18, 1016-1018. doi: 10.1096/fj.03-1110fje
29. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317. doi: 10.1080/14653240600855905
30. Dudley, M. E., Wunderlich, J. R., Yang, J. C., Sherry, R. M., Topalian, S. L., Restifo N. P., et al. (2005). Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J. Clin. Oncol. 23, 2346-2357. doi: 10.1200/JCO.2005.00.240
31. Egeblad, M., Rasch, M. G., and Weaver, V. M. (2010). Dynamic interplay between the collagen scaffold and tumor evolution. Curr. Opin. Cell Biol. 22, 697-706. doi: 10.1016/j.ceb.2010.08.015
32. Eguizabal, C., Zenarruzabeitia, O., Monge, J., Santos, S., Vesga, M. A., Maruri, N., et al. (2014). Natural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspective. Front. Immunol. 5:439. doi: 10.3389/fimmu.2014.00439
33. Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhofer, N., Kong, C., Le, Q. T., et al. (2006). Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440, 1222-1226. doi: 10.1038/nature04695
34. Esquela-Kerscher, A., and Slack, F. J. (2006). Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269. doi: 10.1038/nrc1840
35. Facciabene, A., Motz, G. T., and Coukos, G. (2012). T-regulatory cells: key players in tumor immune escape and angiogenesis. Cancer Res. 72, 2162-2171. doi: 10.1158/0008-5472.CAN-11-3687
36. Folkman, J. (1971). Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182-1186. doi: 10.1056/NEJM197111182852108
37. Folkman, J., Merler, E., Abernathy, C., and Williams, G. (1971). Isolation of a tumor factor responsible for angiogenesis. J. Exp. Med. 133, 275-288. doi: 10.1084/jem.133.2.275
38. Gabriely, G., Wurdinger, T., Kesari, S., Esau, C. C., Burchard, J., Linsley, P. S., et al. (2008). MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol. Cell. Biol. 28, 5369-5380. doi: 10.1128/MCB.00479-08
39. Gao, Q., Qiu, S. J., Fan, J., Zhou, J., Wang, X. Y., Xiao, Y. S., et al. (2007). Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J. Clin. Oncol. 25, 2586-2593. doi: 10.1200/JCO.2006.09.4565
40. Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., et al. (2003). VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 161, 1163-1177. doi: 10.1083/jcb.200302047
41. Gillard-Bocquet, M., Caer, C., Cagnard, N., Crozet, L., Perez, M., Fridman, W., et al. (2013). Lung tumor microenvironment induces specific gene expression signature in intratumoral NK cells. Front. Immunol. 4:19. doi: 10.3389/fimmu.2013.00019
42. Gonzalez-Villasana, V., Fuentes-Mattei, E., Ivan, C., Dalton, H. J., Rodriguez-Aguayo, C., Fernandez-de Thomas, R. J., et al. (2015). Rac1/Pak1/p38/MMP-2 axis regulates angiogenesis in ovarian cancer. Clin. Cancer Res. 21, 2127-2137. doi: 10.1158/1078-0432.CCR-14-2279
43. Grange, C., Collino, F., Tapparo, M., and Camussi, G. (2014). Oncogenic micro-RNAs and Renal Cell Carcinoma. Front. Oncol. 4:49. doi: 10.3389/fonc.2014.00049
44. Gu, P., Xing, X., Tanzer, M., Rocken, C., Weichert, W., Ivanauskas, A., et al. (2008). Frequent loss of TIMP-3 expression in progression of esophageal and gastric adenocarcinomas. Neoplasia 10, 563-572. doi: 10.1593/neo.08208
45. Gu, X., Fu, M., Ding, Y., Ni, H., Zhang, W., Zhu, Y., et al. (2014). TIMP-3 expression associates with malignant behaviors and predicts favorable survival in HCC. PLoS ONE 9:e106161. doi: 10.1371/journal.pone.0106161
46. Hayward, S. W., Wang, Y., Cao, M., Hom, Y. K., Zhang, B., Grossfeld, G. D., et al. (2001). Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res. 61, 8135-8142
47. Hersh, E. M., Mavligit, G. M., Gutterman, J. U., and Barsales, P. B. (1976). Mononuclear cell content of human solid tumors. Med. Pediatr. Oncol. 2, 1-9. doi: 10.1002/mpo.2950020102
48. Hill, R., Song, Y., Cardiff, R. D., and Van Dyke, T. (2005). Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 123, 1001-1011. doi: 10.1016/j.cell.2005.09.030
49. Hynes, R. O. (2002). Integrins: bidirectional, allosteric signaling machines. Cell 110, 673-687. doi: 10.1016/S0092-8674(02)00971-6
50. Hynes, R. O. (2009). The extracellular matrix: not just pretty fibrils. Sciencel 326, 1216-1219. doi: 10.1126/science.1176009
51. Ioachim, E., Charchanti, A., Briasoulis, E., Karavasilis, V., Tsanou, H., Arvanitis, D., et al. (2002). Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. Eur. J. Cancer 38, 2362-2370. doi: 10.1016/S0959-8049(02)00210-1
52. Jones, P. A., and DeClerck, Y. A. (1980). Destruction of extracellular matrices containing glycoproteins, elastin, and collagen by metastatic human tumor cells. Cancer Res. 40, 3222-3227
53. Jue, S. F., Bradley, R. S., Rudnicki, J. A., Varmus, H. E., and Brown, A. M. (1992). The mouse Wnt-1 gene can act via a paracrine mechanism in transformation of mammary epithelial cells. Mol. Cell. Biol. 12, 321-328
54. Kalluri, R., and Weinberg, R. A. (2009). The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420-1428. doi: 10.1172/JCI39104
55. Kalluri, R., and Zeisberg, M. (2006). Fibroblasts in cancer. Nat. Rev. Cancer 6, 392-401. doi: 10.1038/nrc1877
56. Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., et al. (2007). Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557-563. doi: 10.1038/nature06188
57. Karre, K., Ljunggren, H. G., Piontek, G., and Kiessling, R. (1986). Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319, 675-678. doi: 10.1038/319675a0
58. Kikuchi, Y., Kashima, T. G., Nishiyama, T., Shimazu, K., Morishita, Y., Shimazaki, M., et al. (2008). Periostin is expressed in pericryptal fibroblasts and cancer-associated fibroblasts in the colon. J. Histochem. Cytochem. 56, 753-764. doi: 10.1369/jhc.2008.951061
59. Knutson, K. L., and Disis, M. L. (2005). Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol. Immunother. 54, 721-728. doi: 10.1007/s00262-004-0653-2
60. Kuperwasser, C., Chavarria, T., Wu, M., Magrane, G., Gray, J. W., Carey, L., et al. (2004). Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl. Acad. Sci. U.S.A. 101, 4966-4971. doi: 10.1073/pnas.0401064101
61. Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., et al. (2009). Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139, 891-906. doi: 10.1016/j.cell.2009.10.027
62. Lieu, C. H., Tran, H., Jiang, Z. Q., Mao, M., Overman, M. J., Lin, E., et al. (2013). The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer. PLoS ONE 8:e77117. doi: 10.1371/journal.pone.0077117
63. Liu, J., Zhang, N., Li, Q., Zhang, W., Ke, F., Leng, Q., et al. (2011a). Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice. PLoS ONE 6:e19495. doi: 10.1371/journal.pone.0019495
64. Liu, M., Tang, Q., Qiu, M., Lang, N., Li, M., Zheng, Y., et al. (2011b). miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells. FEBS Lett. 585, 2998-3005. doi: 10.1016/j.febslet.2011.08.014
65. Lu, P., Weaver, V. M., and Werb, Z. (2012). The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 196, 395-406. doi: 10.1083/jcb.201102147
66. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., and Sica, A. (2002). Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555. doi: 10.1016/S1471-4906(02)02302-5
67. Mariyama, M., Kalluri, R., Hudson, B. G., and Reeders, S. T. (1992). The alpha 4(IV) chain of basement membrane collagen. Isolation of cDNAs encoding bovine alpha 4(IV) and comparison with other type IV collagens. J. Biol. Chem. 267, 1253-1258
68. Marsh, T., Pietras, K., and McAllister, S. S. (2013). Fibroblasts as architects of cancer pathogenesis. Biochim. Biophys. Acta 1832, 1070-1078. doi: 10.1016/j.bbadis.2012.10.013
69. Matsushita, H., Hosoi, A., Ueha, S., Abe, J., Fujieda, N., Tomura, M., et al. (2015). Cytotoxic T Lymphocytes Block Tumor Growth Both by Lytic Activity and IFNγ-Dependent Cell-Cycle Arrest. Cancer Immunol. Res. 3, 26-36. doi: 10.1158/2326-6066.CIR-14-0098
70. McCawley, L. J., and Matrisian, L. M. (2000). Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol. Med. Today 6, 149-156. doi: 10.1016/S1357-4310(00)01686-5
71. Menetrier-Caux, C., Montmain, G., Dieu, M. C., Bain, C., Favrot, M. C., Caux, C., et al. (1998). Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 92, 4778-4791
72. Mirnezami, A. H., Pickard, K., Zhang, L., Primrose, J. N., and Packham, G. (2009). MicroRNAs: key players in carcinogenesis and novel therapeutic targets. Eur. J. Surg. Oncol. 35, 339-347. doi: 10.1016/j.ejso.2008.06.006
73. Mishra, P. J., Mishra, P. J., Humeniuk, R., Medina, D. J., Alexe, G., Mesirov, J. P., et al. (2008). Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res. 68, 4331-4339. doi: 10.1158/0008-5472.CAN-08-0943
74. Moretta, A. (2002). Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat. Rev. Immunol. 2, 957-964. doi: 10.1038/nri956
75. Moses, H. L., Branum, E. L., Proper, J. A., and Robinson, R. A. (1981). Transforming growth factor production by chemically transformed cells. Cancer Res. 41, 2842-2848
76. Murphy, B. C., Pienta, K. J., and Coffey, D. S. (1992). Effects of extracellular matrix components and dihydrotestosterone on the structure and function of human prostate cancer cells. Prostate 20, 29-41. doi: 10.1002/pros.2990200105
77. Nam, J. M., Onodera, Y., Bissell, M. J., and Park, C. C. (2010). Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin. Cancer Res. 70, 5238-5248. doi: 10.1158/0008-5472.CAN-09-2319
78. Nickell, K. A., Halper, J., and Moses, H. L. (1983). Transforming growth factors in solid human malignant neoplasms. Cancer Res. 43, 1966-1971
79. Nielsen, B. S., Jorgensen, S., Fog, J. U., Sokilde, R., Christensen, I. J., Hansen, U., et al. (2011). High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin. Exp. Metastasis 28, 27-38. doi: 10.1007/s10585-010-9355-7
80. Noy, R., and Pollard, J. W. (2014). Tumor-associated macrophages: from mechanisms to therapy. Immunity 41, 49-61. doi: 10.1016/j.immuni.2014.06.010
81. Ohlund, D., Franklin, O., Lundberg, E., Lundin, C., and Sund, M. (2013). Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop. BMC Cancer 13:154. doi: 10.1186/1471-2407-13-154
82. Ohmura, Y., Yoshikawa, K., Saga, S., Ueda, R., Kazaoka, Y., and Yamada, S. (2008). Combinations of tumor-specific CD8+ CTLs and anti-CD25 mAb provide improved immunotherapy. Oncol. Rep. 19, 1265-1270. doi: 10.3892/or.19.5.1265
83. Olumi, A. F., Grossfeld, G. D., Hayward, S. W., Carroll, P. R., Tlsty, T. D., and Cunha, G. R. (1999). Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59, 5002-5011
84. Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., et al. (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348. doi: 10.1016/j.cell.2005.02.034
85. Otrock, Z. K., Mahfouz, R. A., Makarem, J. A., and Shamseddine, A. I. (2007). Understanding the biology of angiogenesis: review of the most important molecular mechanisms. Blood Cells Mol. Dis. 39, 212-220. doi: 10.1016/j.bcmd.2007.04.001
86. Paget, S. (1889). The distribution of secondary growths in cancers of the breast. Lancet 133, 571-573. doi: 10.1016/S0140-6736(00)49915-0
87. Pietras, K., Pahler, J., Bergers, G., and Hanahan, D. (2008). Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting. PLoS Med. 5:e19. doi: 10.1371/journal.pmed.0050019
88. Qi, J. H., Ebrahem, Q., Moore, N., Murphy, G., Claesson-Welsh, L., Bond, M., et al. (2003). A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat. Med. 9, 407-415. doi: 10.1038/nm846
89. Quante, M., Tu, S. P., Tomita, H., Gonda, T., Wang, S. S., Takashi, S., et al. (2011). Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell 19, 257-272. doi: 10.1016/j.ccr.2011.01.020
90. Rabinovich, G. A. (2005). Galectin-1 as a potential cancer target. Br. J. Cancer 92, 1188-1192. doi: 10.1038/sj.bjc.6602493
91. Rech, A. J., Mick, R., Martin, S., Recio, A., Aqui, N. A., Powell, D. J. Jr., et al. (2012). CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients. Sci. Transl. Med. 4:134ra162. doi: 10.1126/scitranslmed.3003330
92. Recklies, A. D., Tiltman, K. J., Stoker, T. A., and Poole, A. R. (1980). Secretion of proteinases from malignant and nonmalignant human breast tissue. Cancer Res. 40, 550-556
93. Reis, S. T., Pontes-Junior, J., Antunes, A. A., Dall'Oglio, M. F., Dip, N., Passerotti, C., et al. (2012). miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer. BMC Urol. 12:14. doi: 10.1186/1471-2490-12-14
94. Roberti, M. P., Rocca, Y. S., Amat, M., Pampena, M. B., Loza, J., Coló, F., et al. (2012). IL-2-or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients. Breast Cancer Res. Treat. 136, 659-671. doi: 10.1007/s10549-012-2287-y
95. Roskelley, C. D., Desprez, P. Y., and Bissell, M. J. (1994). Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proc. Natl. Acad. Sci. U.S.A. 91, 12378-12382. doi: 10.1073/pnas.91.26.12378
96. Russel, S. W., Doe, W. F., and Cochrane, C. G. (1976). Number of macrophages and distribution of mitotic activity in regressing and progressing Moloney sarcomas. J. Immunol. 116, 164-166
97. Sadej, R., Inai, K., Rajfur, Z., Ostapkowicz, A., Kohler, J., Skladanowski, A., et al. (2008). Tenascin C interacts with ecto-5'-nucleotidase (eN) and regulates adenosine generation in cancer cells. Biochim. Biophys. Acta 1782, 35-40. doi: 10.1016/j.bbadis.2007.11.001
98. Schiavoni, G., Gabriele, L., and Mattei, F. (2013). The tumor microenvironment: a pitch for multiple players. Front. Oncol. 3:90. doi: 10.3389/fonc.2013.00090
99. Skuli, N., Liu, L., Runge, A., Wang, T., Yuan, L., Patel, S., et al. (2009). Endothelial deletion of hypoxia-inducible factor-2alpha (HIF-2alpha) alters vascular function and tumor angiogenesis. Blood 114, 469-477. doi: 10.1182/blood-2008-12-193581
100. Solinas, G., Germano, G., Mantovani, A., and Allavena, P. (2009). Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J. Leukoc. Biol. 86, 1065-1073. doi: 10.1189/jlb.0609385
101. Sprent, J. (1995). Antigen-presenting cells. Professionals and amateurs. Curr. Biol. 5, 1095-1097. doi: 10.1016/S0960-9822(95)00219-3
102. Surman, D. R., Dudley, M. E., Overwijk, W. W., and Restifo, N. P. (2000). Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen. J. Immunol. 164, 562-565. doi: 10.4049/jimmunol.164.2.562
103. Tang, N., Wang, L., Esko, J., Giordano, F. J., Huang, Y., Gerber, H. P., et al. (2004). Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 6, 485-495. doi: 10.1016/j.ccr.2004.09.026
104. Tatsumi, T., Herrem, C. J., Olson, W. C., Finke, J. H., Bukowski, R. M., Kinch, M. S., et al. (2003). Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinoma. Cancer Res. 63, 4481-4489
105. Tatsumi, T., Kierstead, L. S., Ranieri, E., Gesualdo, L., Schena, F. P., Finke, J. H., et al. (2002). Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma. J. Exp. Med. 196, 619-628. doi: 10.1084/jem.20012142
106. Ucar, A., Vafaizadeh, V., Jarry, H., Fiedler, J., Klemmt, P. A., Thum, T., et al. (2010). miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development. Nat. Genet. 42, 1101-1108. doi: 10.1038/ng.709
107. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J. J., and Lotvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659. doi: 10.1038/ncb1596
108. Verbeke, H., Struyf, S., Laureys, G., and Van Damme, J. (2011). The expression and role of CXC chemokines in colorectal cancer. Cytokine Growth Factor Rev. 22, 345-358. doi: 10.1016/j.cytogfr.2011.09.002
109. Vesely, M. D., Kershaw, M. H., Schreiber, R. D., and Smyth, M. J. (2011). Natural innate and adaptive immunity to cancer. Annu. Rev. Immunol. 29, 235-271. doi: 10.1146/annurev-immunol-031210-101324
110. Vlodavsky, I., and Friedmann, Y. (2001). Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J. Clin. Invest. 108, 341-347. doi: 10.1172/JCI13662
111. Wang, Y., Kim, S., and Kim, I. M. (2014). Regulation of metastasis by microRNAs in ovarian cancer. Front. Oncol. 4:143. doi: 10.3389/fonc.2014.00143
112. Wilson, E. B., El-Jawhari, J. J., Neilson, A. L., Hall, G. D., Melcher, A. A., Meade, J. L., et al. (2011). Human tumour immune evasion via TGF-beta blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity. PLoS ONE 6:e22842. doi: 10.1371/journal.pone.0022842
113. Witz, I. P. (2009). The tumor microenvironment: the making of a paradigm. Cancer Microenviron. 2(Suppl. 1), 9-17. doi: 10.1007/s12307-009-0025-8
114. Wong, B. W., Kuchnio, A., Bruning, U., and Carmeliet, P. (2013). Emerging novel functions of the oxygen-sensing prolyl hydroxylase domain enzymes. Trends Biochem. Sci. 38, 3-11. doi: 10.1016/j.tibs.2012.10.004
115. Xu, Z., Vonlaufen, A., Phillips, P. A., Fiala-Beer, E., Zhang, X., Yang, L., et al. (2010). Role of pancreatic stellate cells in pancreatic cancer metastasis. Am. J. Pathol. 177, 2585-2596. doi: 10.2353/ajpath.2010.090899
116. Yang, M., Chen, J., Su, F., Yu, B., Su, F., Lin, L., et al. (2011). Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol. Cancer 10:117. doi: 10.1186/1476-4598-10-117
117. Yu, Y., Xiao, C. H., Tan, L. D., Wang, Q. S., Li, X. Q., and Feng, Y. M. (2014). Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-beta signalling. Br. J. Cancer 110, 724-732. doi: 10.1038/bjc.2013.768
118. Zhou, B., Chen, W. L., Wang, Y. Y., Lin, Z. Y., Zhang, D. M., Fan, S., et al. (2014). A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma. J. Oral Pathol. Med. 43, 585-592. doi: 10.1111/jop.12172